COVID-19

News

Disputed COVID-19 trial failure reports send Gilead shares d...

Gilead's COVID-19 drug remdesivir seemingly failed to produce an effect according to results of a Chinese clinical trial posted inadvertently on the World Health Organizatio

Views & Analysis

Coronavirus pharma news roundup – 24/04/2020

Research into drugs that could treat or prevent COVID-19 continued full steam ahead this week as the industry puts all its resources into fighting the coronavirus pandemic.

Views & Analysis

COVID-19 and premature babies: Locking down to protect their...

Everyone is living with a certain degree of COVID-19-related fear and anxiety at the moment – but spare a thought for the parents of premature and sick babies.

News

UK digital firms help train new medical recruits to fight CO...

Healthtech startups Patchwork Health and Medics.Academy have joined forces to produce a tool to help newly-qualified doctors and returning retired doctors get trained for the effort against

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

R&D

The new global digital health paradigm in life sciences

Digital transformation has long been a priority for all life science companies and it has been made even more pressing by the current health emergency caused by COVID-19.

News

Gilead shares jump after rethink of COVID-19 remdesivir tria...

Shares in Gilead were up in premarket trading after the company announced it had increased the size of its trials for its COVID-19 drug remdesivir.

Disputed COVID-19 trial failure reports send Gilead shares d...

Coronavirus pharma news roundup – 24/04/2020

COVID-19 and premature babies: Locking down to protect their...

UK digital firms help train new medical recruits to fight CO...

The new global digital health paradigm in life sciences

Gilead shares jump after rethink of COVID-19 remdesivir tria...

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks